Mallinckrodt PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
117.34 M |
Public Float |
- |
Mallinckrodt PLC | |
Stock Exchange | New York Stock Exchange |
EPS |
$41.28 |
Market Cap |
$724.15 M |
Shares Outstanding |
83.81 M |
Public Float |
82.28 M |
Address |
3 Lotus Park Staines-Upon-Thames Surrey TW18 3AG United Kingdom |
Employees | - |
Website | http://mallinckrodt.com |
Updated | 07/08/2019 |
Mallinckrodt Plc operates as a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. |